Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Riken Vitamin Co., Ltd. ( (JP:4526) ) has shared an announcement.
Riken Vitamin Co., Ltd. reported its consolidated financial results for the six months ended September 30, 2025, showing a slight increase in net sales by 0.2% to ¥47,265 million. However, operating profit decreased by 11.6% to ¥4,091 million. The company maintained a stable equity ratio of 71.5% and announced an increase in dividends, reflecting a positive outlook for stakeholders.
The most recent analyst rating on (JP:4526) stock is a Buy with a Yen3244.00 price target. To see the full list of analyst forecasts on Riken Vitamin Co., Ltd. stock, see the JP:4526 Stock Forecast page.
More about Riken Vitamin Co., Ltd.
Riken Vitamin Co., Ltd. is a company listed on the Tokyo Stock Exchange, primarily engaged in the production and sale of vitamins and related products. The company focuses on providing nutritional solutions and has a significant presence in the health and wellness industry.
Average Trading Volume: 77,880
Technical Sentiment Signal: Buy
Current Market Cap: Yen65.1B
Learn more about 4526 stock on TipRanks’ Stock Analysis page.